These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8729907)

  • 61. Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells.
    Wiechen K; Karaaslan S; Turzynski A; Dietel M
    Br J Cancer; 1999 Nov; 81(5):790-5. PubMed ID: 10555747
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.
    Gandhi A; Holland PA; Knox WF; Potten CS; Bundred NJ
    Br J Cancer; 1998 Sep; 78(6):788-94. PubMed ID: 9743302
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeted tumor killing via an intracellular antibody against erbB-2.
    Deshane J; Siegal GP; Alvarez RD; Wang MH; Feng M; Cabrera G; Liu T; Kay M; Curiel DT
    J Clin Invest; 1995 Dec; 96(6):2980-9. PubMed ID: 8675670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody.
    Deshane J; Cabrera G; Grim JE; Siegal GP; Pike J; Alvarez RD; Curiel DT
    Gynecol Oncol; 1995 Oct; 59(1):8-14. PubMed ID: 7557620
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
    Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
    Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines.
    Deshane J; Loechel F; Conry RM; Siegal GP; King CR; Curiel DT
    Gene Ther; 1994 Sep; 1(5):332-7. PubMed ID: 7584099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel gene therapy strategy to accomplish growth factor modulation induces enhanced tumor cell chemosensitivity.
    Barnes MN; Deshane JS; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1996 Jul; 2(7):1089-95. PubMed ID: 9816272
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.
    Deshane J; Grim J; Loechel S; Siegal GP; Alvarez RD; Curiel DT
    Cancer Gene Ther; 1996; 3(2):89-98. PubMed ID: 8729907
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.